Radical hysterectomy in early cervical cancer in Europe: characteristics, outcomes and evaluation of ESGO quality indicators
Felix Boria 1 , Luis Chiva 2 , Vanna Zanagnolo 3 , Denis Querleu 4 , Nerea Martin-Calvo 5 , Mihai Emil Căpîlna 6 , Anna Fagotti 7 , Ali Kucukmetin 8 , Constantijne Mom 9 , Galina Chakalova 10 , Aliyev Shamistan 11 , Mario Malzoni 12 , Fabrice Narducci 13 , Octavio Arencibia 14 , Francesco Raspagliesi 15 , Tayfun Toptas 16 , David Cibula 17 , Dilyara Kaidarova 18 , Mehmet Mutlu Meydanli 19 , Mariana Tavares 20 , Dmytro Golub 21 , Anna Myriam Perrone 22 , Robert Poka 23 , Dimitrios Tsolakidis 24 , Goran Vujić 25 , Marcin A Jedryka 26 , Petra L M Zusterzeel 27 , Jogchum Jan Beltman 28 , Frederic Goffin 29 , Dimitrios Haidopoulos 30 , Herman Haller 31 , Robert Jach 32 , Iryna Yezhova 33 , Igor Berlev 34 , Margarida Bernardino 35 , Rasiah Bharathan 36 , Maximilian Lanner 37 , Minna M Maenpaa 38 , Vladyslav Sukhin 39 40 , Jean-Guillaume Feron 41 , Robert Fruscio 42 43 , Kersti Kukk 44 , Jordi Ponce 45 , María Alonso-Espías 46 , Jose Angel Minguez 47 , Daniel Vázquez-Vicente 48 , Nabil Manzour 49 , Matias Jurado 47 , Teresa Castellanos 48 , Enrique Chacon 50 , Juan Luis Alcazar 51
Introduction: Comprehensive updated information on cervical cancer surgical treatment in Europe is scarce.
Objective: To evaluate baseline characteristics of women with early cervical cancer and to analyze the outcomes of the ESGO quality indicators after radical hysterectomy in the SUCCOR database.
Methods: The SUCCOR database consisted of 1272 patients who underwent radical hysterectomy for stage IB1 cervical cancer (FIGO 2009) between January 2013 and December 2014. After exclusion criteria, the final sample included 1156 patients. This study first described the clinical, surgical, pathological, and follow-up variables of this population and then analyzed the outcomes (disease-free survival and overall survival) after radical hysterectomy. Surgical-related ESGO quality indicators were assessed and the accomplishment of the stated recommendations was verified.
Results: The mean age of the patients was 47.1 years (SD 10.8), with a mean body mass index of 25.4 kg/m2 (SD 4.9). A total of 423 (36.6%) patients had a previous cone biopsy. Tumor size (clinical examination) <2 cm was observed in 667 (57.7%) patients. The most frequent histology type was squamous carcinoma (794 (68.7%) patients), and positive lymph nodes were found in 143 (12.4%) patients. A total of 633 (54.8%) patients were operated by open abdominal surgery. Intra-operative complications occurred in 108 (9.3%) patients, and post-operative complications during the first month occurred in 249 (21.5%) patients, with bladder dysfunction as the most frequent event (119 (10.3%) patients). Clavien-Dindo grade III or higher complication occurred in 56 (4.8%) patients. A total of 510 (44.1%) patients received adjuvant therapy. After a median follow-up of 58 months (range 0-84), the 5-year disease-free survival was 88.3%, and the overall survival was 94.9%. In our population, 10 of the 11 surgical-related quality indicators currently recommended by ESGO were fully fulfilled 5 years before its implementation.
Conclusions: In this European cohort, the rate of adjuvant therapy after radical hysterectomy is higher than for most similar patients reported in the literature. The majority of centers were already following the European recommendations even 5 years prior to the ESGO quality indicator implementations.
CITA DEL ARTÍCULO Int J Gynecol Cancer. 2021 Jul 28;ijgc-2021-002587. doi: 10.1136/ijgc-2021-002587